Search

Arthur J Raitano

from Bellflower, CA
Age ~57

Arthur Raitano Phones & Addresses

  • 17634 Windward Ter, Bellflower, CA 90706 (562) 866-9845 (714) 867-3728 (562) 673-3100
  • 10030 Rosecrans Ave #18, Bellflower, CA 90706 (562) 867-3728
  • 5429 Pine Ave, Chino Hills, CA 91709
  • Las Vegas, NV
  • 12927 Boston Ave, Chino, CA 91710 (951) 342-9765 (909) 342-9765
  • Ontario, CA
  • Concord, CA
  • La Habra, CA
  • Los Angeles, CA
  • 17634 Windward Ter, Bellflower, CA 90706

Public records

Vehicle Records

Arthur Raitano

View page
Address:
17634 Windward Ter, Bellflower, CA 90706
Phone:
(310) 530-3954
VIN:
1G2MB35B97Y104798
Make:
PONTIAC
Model:
SOLSTICE
Year:
2007

Business Records

Name / Title
Company / Classification
Phones & Addresses
Arthur E Raitano
Treasurer
E.J. DE LA ROSA & CO., INC
Security Broker/Dealer · Security Broker/Dealer Closed-End Investment Office
2121 Ave Of The Stars, Los Angeles, CA 90067
10866 Wilshire Blvd, Los Angeles, CA 90024
(310) 207-1975, (310) 207-1995

Publications

Us Patents

36P6D5: Secreted Tumor Antigen

View page
US Patent:
6566078, May 20, 2003
Filed:
Oct 30, 2000
Appl. No.:
09/702114
Inventors:
Arthur B. Raitano - Los Angeles CA
Aya Jakobovits - Beverly Hills CA
Mary Faris - Los Angeles CA
Daniel E. H. Afar - Brisbane CA
Rene S. Hubert - Los Angeles CA
Steve Chappell Mitchell - Santa Monica CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
G01N 3353
US Classification:
435 71, 435 72, 435 723, 530350, 5303871, 53038885, 5303891
Abstract:
Described is a gene and its encoded secreted tumor antigen, termed 36P6D5, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express 36P6D5, particularly including cancers of the bladder, kidney, prostate, breast, colon, ovary and pancreas.

C-Type Lectin Transmembrane Antigen Expressed In Human Prostate Cancer And Uses Thereof

View page
US Patent:
6602501, Aug 5, 2003
Filed:
Aug 11, 2000
Appl. No.:
09/638203
Inventors:
Daniel E. H. Afar - Pacific Palisades CA
Rene S. Hubert - Los Angeles CA
Aya Jakobovits - Beverly Hills CA
Arthur B. Raitano - Los Angeles CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
A61K 39395
US Classification:
4241301, 4241331, 4241351, 4241381, 4241391, 4241411, 4241421, 5303877, 5303881, 53038815, 5303888, 53038885, 5303891, 5303897

Ptans: Testis Specific Proteins Expressed In Prostate Cancer

View page
US Patent:
6652859, Nov 25, 2003
Filed:
Sep 30, 1999
Appl. No.:
09/409938
Inventors:
Daniel E. Afar - Pacific Palisades CA
Rene S. Hubert - Los Angeles CA
Arthur B. Raitano - Los Angeles CA
Stephen Chappell Mitchell - Santa Monica CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
A61K 3900
US Classification:
4241851, 530326, 530350, 4242771
Abstract:
Novel testis-specific genes and encoded proteins (PTANs) are described. PTANs are over-expressed in prostate cancer. The nucleotide and amino acid sequences of three distinct PTAN isoforms, designated PTAN-1, PTAN-2 and PTAN-3 are provided. The PTANs show no homology to any known gene. The testis-specific expression profile of PTAN in normal adult tissues, combined with the over-expression observed in prostate tumor xenografts, suggests that PTAN may be aberrancy over-expressed in at least some prostate cancers, and thus may be a useful diagnostic and/or therapeutic target for prostate cancers.

G Protein-Coupled Receptor Up-Regulated In Prostate Cancer And Uses Thereof

View page
US Patent:
6790631, Sep 14, 2004
Filed:
Oct 5, 2000
Appl. No.:
09/680728
Inventors:
Arthur B. Raitano - Los Angeles CA
Daniel E. H. Afar - Brisbane CA
Aya Jakobovits - Beverly Hills CA
Mary Faris - Los Angeles CA
Rene S. Hubert - Los Angeles CA
Steve Chappell Mitchell - Santa Monica CA
Douglas C. Saffran - Los Angeles CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
G01M 3353
US Classification:
435 723, 435 71, 530350, 5303871, 4241851
Abstract:
A novel gene (designated PHOR-1) that is highly over-expressed in prostate and other cancers and its encoded protein are described. PHOR-1 is a G protein-coupled receptor with homology to receptors involved in olfaction. PHOR-1 in normal human tissues is restricted to prostate, and this gene is highly over-expressed in prostate cancer as well as in cancers of the kidney, uterus, cervix, stomach and rectum. Consequently, PHOR-1 provides a diagnostic and/or therapeutic target for prostate cancer.

Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof

View page
US Patent:
6833438, Dec 21, 2004
Filed:
Dec 6, 1999
Appl. No.:
09/455486
Inventors:
Daniel E. Afar - Pacific Palisades CA
Rene S. Hubert - Los Angeles CA
Arthur B. Raitano - Los Angeles CA
Douglas C. Saffran - Los Angeles CA
Stephen Chappell Mitchell - Santa Monica CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
C07K 1100
US Classification:
530350, 514 2, 514 21, 435975
Abstract:
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed âSTEAPâ ( ix ransmembrane pithelial ntigen of the rostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a âserpentineâ manner into three extracellular and two intracellular loops. STEAP-1 protein expression is maintained at high levels across various stages of prostate cancer.

Diagnosis And Therapy Of Cancer Using Sgp28-Related Molecules

View page
US Patent:
6835822, Dec 28, 2004
Filed:
Oct 27, 2000
Appl. No.:
09/698781
Inventors:
Rene S. Hubert - Los Angeles CA
Arthur B. Raitano - Los Angeles CA
Daniel E. H. Afar - Brisbane CA
Steve Chappell Mitchell - Santa Monica CA
Mary Faris - Los Angeles CA
Aya Jakobovits - Beverly Hills CA
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
C07H 2104
US Classification:
536 235, 530300, 530350, 536 231, 536 2431, 536 2433, 4241851
Abstract:
The present invention relates to methods and compositions for the diagnosis and therapy of prostate cancer which utilize isolated polynucleotides corresponding to the human SGP28 gene, proteins encoded by the SGP28 gene and fragments thereof, and antibodies capable of specifically recognizing and binding to SGP28 proteins.

G Protein-Coupled Receptor Up-Regulated In Prostate Cancer And Uses Thereof

View page
US Patent:
6838258, Jan 4, 2005
Filed:
Dec 14, 2001
Appl. No.:
10/017066
Inventors:
Arthur B. Raitano - Los Angeles CA, US
Daniel E. H. Afar - Brisbane CA, US
Aya Jakobovits - Beverly Hills CA, US
Mary Faris - Los Angeles CA, US
Rene S. Hubert - Los Angeles CA, US
Steve Chappell Mitchell - Santa Monica CA, US
Douglas C. Saffran - Los Angeles CA, US
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
C12P 2106
US Classification:
435 691, 4352523, 4353201, 435326, 536 231, 536 243, 530350
Abstract:
A novel gene (designated PHOR-1) that is highly overdressed in prostate and other cancers and its encoded protein are described. PHOR-1 is a G protein-coupled receptor with homology to receptors involved in olfaction. PHOR-1 in normal human tissues is restricted to prostate, and this gene is highly over-expressed in prostate cancer as well as in cancers of the kidney, uterus, cervix, stomach and rectum. Consequently, PHOR-1 provides a diagnostic and/or therapeutic target for prostate cancer.

Nucleic Acid And Corresponding Protein Named 158P1D7 Useful In The Treatment And Detection Of Bladder And Other Cancers

View page
US Patent:
6863892, Mar 8, 2005
Filed:
Aug 22, 2001
Appl. No.:
09/935430
Inventors:
Mary Faris - Los Angeles CA, US
Rene S. Hubert - Los Angeles CA, US
Arthur B. Raitano - Los Angeles CA, US
Daniel E. H. Afar - Brisbane CA, US
Elana Levin - Los Angeles CA, US
Pia Challita-Eid - Encino CA, US
Aya Jakobovits - Beverly Hills CA, US
Assignee:
Agensys, Inc. - Santa Monica CA
International Classification:
A61K039/00
A61K039/38
C12Q001/00
C12Q001/68
G01N033/53
US Classification:
4241851, 4241841, 435 4, 435 6, 435 71, 435 721, 435 723, 435 691, 435 701, 435 702, 435 7021, 514 1, 514 2, 514 8, 514 12, 514 42, 514 43, 514 44, 530300, 530350, 530385, 5303871, 5303877, 5303879, 5303881, 536 111, 536 187, 536 234, 536 235
Abstract:
A novel gene (designated 158P1D7) and its encoded protein are described. While 158P1D7 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1D7 provides a diagnostic and/or therapeutic target for cancers. The 158P1D7 gene or fragment thereof, or its encoded protein or a fragment thereof, can be used to elicit an immune response.
Arthur J Raitano from Bellflower, CA, age ~57 Get Report